Literature DB >> 7114639

The emergence of methicillin-resistant Staphylococcus aureus.

R P Wenzel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7114639     DOI: 10.7326/0003-4819-97-3-440

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  27 in total

1.  In vitro synergistic activity between meropenem and other beta-lactams against methicillin-resistant Staphylococcus aureus.

Authors:  Y Sumita; S Mitsuhashi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

2.  Clonal heterogeneity, distribution, and pathogenicity of methicillin-resistant Staphylococcus aureus.

Authors:  T A Wichelhaus; J Schulze; K P Hunfeld; V Schäfer; V Brade
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-12       Impact factor: 3.267

Review 3.  Antimicrobial resistance of Staphylococcus aureus: genetic basis.

Authors:  B R Lyon; R Skurray
Journal:  Microbiol Rev       Date:  1987-03

4.  In vitro effects of beta-lactams combined with beta-lactamase inhibitors against methicillin-resistant Staphylococcus aureus.

Authors:  S Kobayashi; S Arai; S Hayashi; T Sakaguchi
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

5.  In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus.

Authors:  S M Smith
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

6.  In vitro and in vivo study of fosfomycin in methicillin-resistant Staphylococcus aureus septicaemia.

Authors:  W Y Lau; C H Teoh-Chan; S T Fan; K F Lau
Journal:  J Hyg (Lond)       Date:  1986-06

7.  In vitro activity of AT-4140 against clinical bacterial isolates.

Authors:  T Kojima; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

8.  Epidemiologic study of Staphylococcus strains isolated from clinical material in 24 Italian hospitals.

Authors:  P E Varaldo
Journal:  Eur J Epidemiol       Date:  1986-09       Impact factor: 8.082

9.  In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus.

Authors:  S H Guenthner; R P Wenzel
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

10.  Clinical comparative study on the activity of cefamandole in the treatment of serious staphylococcal infections caused by methicillin-susceptible and methicillin-resistant strains.

Authors:  R F Frongillo; L Donati; G Federico; P Martino; M Moroni; L Ortona; M Palumbo; B M Pasticci; E Pizzigallo; G Privitera
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.